Literature DB >> 16998334

Treatment of facial angiofibroma of tuberous sclerosis using cultured epithelial autografts.

Keijiro Hori1, Kazutaka Soejima, Motohiro Nozaki, Hiroyuki Sakurai, Masaki Takeuchi, Takashi Yamaki, Susumu Iwasaka, Taro Kono, Takashi Honda, Tsukasa Isago.   

Abstract

Treatment of facial angiofibroma of tuberous sclerosis is problematic, because the skin lesions involve entire dermis. Five patients aged from 14 to 33 (mean: 23.6) years old with angiofibroma of tuberous sclerosis were treated with cultured epithelial autografts between 1995 and 2004. The entire area of the facial lesions was excised using a razor to remove large nodules, and then the remaining lesions were further abraded to a rather deep layer of the dermis to smooth the skin and remove small nodules. Then a cultured autologous epithelium was grafted onto the wound. In all patients, epithelization was complete within 10 (mean: 9) days after the surgery. All patients were followed up for more than 6 months and showed neither depigmentation due to scar formation nor hypertrophic scars. In some patients, some pebbly regrowth had occurred at 5 years postoperatively, but the appearance was quite acceptable.

Entities:  

Mesh:

Year:  2006        PMID: 16998334     DOI: 10.1097/01.sap.0000221621.34715.21

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  3 in total

1.  Radiofrequency ablation of adenoma sebaceum.

Authors: 
Journal:  J Cutan Aesthet Surg       Date:  2008-07

2.  [Laser skin resurfacing and fibrin sealing as successful treatment for facial angiofibromas in tuberous sclerosis].

Authors:  A Pantelis; F Bootz; T Kühnel
Journal:  HNO       Date:  2007-12       Impact factor: 1.284

3.  Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin.

Authors:  Mary Kay Koenig; Adelaide A Hebert; Joan Roberson; Joshua Samuels; John Slopis; Audrey Woerner; Hope Northrup
Journal:  Drugs R D       Date:  2012-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.